Evaluation of Effects of Postoperative Adjuvant Therapy with Anastrozole on Bone in Postmenopausal Women with Breast Cancer
- Conditions
- Hormone-responsive postmenopausal breast cancer
- Registration Number
- JPRN-UMIN000000514
- Lead Sponsor
- Saitama Breast Cancer Clinical Study Group (SBCCSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 350
Not provided
1. Active multiple cancer (simultaneous multiple cancer, and multi-organ invasive cancer with less than 5years of event-free survival) 2. Non-invasive cancer, inflammatory breast cancer 3. Patients with history of osteoporosis or BMD is osteoporosis level (less than 70% of young adult mean (YAM)) 4. Patients being treated with bisphosphonate drugs or other osteoporotic drugs 5. Patients diagnosed as having a history of spinal fracure in X-ray or other imagin tests 6. Serious complications (hepatic, renal, cardiac, and endocrine diseases, etc.) 7. Patients with a history of hypersensitivity to any of the ingredients of the study drug 8. Patients judged to be ineligible for participating in the study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method